How is Kisspeptin-10 administered?
This describes how Kisspeptin-10 is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a as needed or 1-2x daily during a short cycle schedule, generally over short bursts; not for chronic use. Specific dosing is individual and beyond general information, and human evidence for Kisspeptin-10 is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: As needed or 1-2x daily during a short cycle
- Cycle length: Short bursts; not for chronic use
- Half-life: ~4 minutes (kisspeptin-10)
References
- Kisspeptin in human reproductive health and disease — Skorupskaite K et al., Hum Reprod Update, 2014
- Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males — Dhillo WS, Chaudhri OB, Thompson EL, et al.; Journal of Clinical Endocrinology & Metabolism; 2005
- Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men — George JT, Veldhuis JD, Roseweir AK, et al.; Journal of Clinical Endocrinology & Metabolism; 2011
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Kisspeptin-10
Last updated 2026-06-15.